Search results for "Protein Precursors"

showing 10 items of 89 documents

Chaperones Involved in Hepatitis B Virus Morphogenesis

1999

Little is known about host cell factors necessary for hepatitis B virus (HBV) assembly which involves envelopment of cytosolic nucleocapsids by the S, M and L transmembrane viral envelope proteins and subsequent budding into intraluminal cisternae. Central to virogenesis is the L protein that mediates hepatocyte receptor binding and envelopment of capsids. To serve these topologically conflicting roles, L protein exhibits an unusual dual membrane topology, disposing its N-terminal preS domain inside and outside of the virion lipid envelope. The mixed topology is achieved by posttranslational preS translocation of about half of the L protein molecules across a post-endoplasmic reticulum memb…

Hepatitis B virusProtein FoldingCalnexinHSC70 Heat-Shock ProteinsClinical BiochemistryBiochemistryViral Matrix ProteinsCytosolViral Envelope ProteinsViral envelopeCalnexinMorphogenesisAnimalsHumansHSP70 Heat-Shock ProteinsProtein PrecursorsMolecular BiologyHepatitis B Surface AntigensViral matrix proteinbiologyChemistryCalcium-Binding ProteinsHSC70 Heat-Shock ProteinsBiological TransportVirologyTransmembrane proteinCell biologyProtein BiosynthesisMembrane topologyChaperone (protein)COS Cellsbiology.proteinProtein foldingCarrier ProteinsMolecular ChaperonesBiological Chemistry
researchProduct

Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation.

1996

Orthotopic liver transplantation (OLT) is a possible treatment for acute or chronic liver failure due to hepatitis B virus (HBV) infection, but reinfection of the graft can be a serious complication. The aim of this study was to monitor HBV markers, to analyse pre-core-/core-mutations as well as to identify the viral population causing reinfection after OLT, and to investigate the emergence or disappearance of these mutants in patients receiving immunosuppressive treatment. Fifty-four pre-and posttransplant serum samples of 17 patients were analysed. All patients underwent OLT for HBV-related liver disease and had HBV-DNA before and after OLT. Total DNA was extracted from all sera and a 240…

Hepatitis B virusTime Factorsmedicine.medical_treatmentPopulationLiver transplantationInterferon alpha-2medicine.disease_causeAntiviral AgentsLiver diseaseVirologyMedicineHumansHepatitis B e AntigensProtein PrecursorseducationHepatitis B viruseducation.field_of_studyHepatitis B Surface Antigensbiologybusiness.industryInterferon-alphaImmunosuppressionSequence Analysis DNAHepatitis Bbiology.organism_classificationmedicine.diseaseHepatitis BVirologyHepatitis B Core AntigensRecombinant ProteinsLiver TransplantationTransplantationsurgical procedures operativeInfectious DiseasesHepadnaviridaeDNA ViralbusinessImmunosuppressive AgentsFollow-Up StudiesJournal of medical virology
researchProduct

Possible role of human interleukin-6 and soluble interleukin-6 receptor in hepatitis B virus infection

2001

Human interleukin-6 has been shown to promote hepatitis B virus (HBV) infection. However, it is not clear whether this influence is the result of a direct interaction between interleukin-6 (IL-6) and the HBV envelope proteins or of a rather indirect mechanism. A direct interaction of IL-6 and the preS region of the large envelope protein (L-protein) of HBV has been reported. In this study we assessed the binding of IL-6 and of the IL-6 receptor subunits to the preS region of the L-protein of HBV. Binding of IL-6 and IL-6 receptor subunits sIL-6R and gp130 to preS was assessed by immunoprecipitation with recombinant preS proteins. In patient sera IL-6 and sIL-6R concentrations were analysed …

Hepatitis B virusmedicine.disease_causeHepatitis B virus PRE betalaw.inventionHepatitis B ChroniclawVirologyEscherichia colimedicineAnimalsHumansProtein PrecursorsInterleukin 6ReceptorCells CulturedHepatitis B virusHepatitis B Surface AntigensHepatologybiologyInterleukin-6Chemistryvirus diseasesViral LoadHepatitis BGlycoprotein 130medicine.diseasePrecipitin TestsReceptors Interleukin-6VirologyMolecular biologyRecombinant ProteinsInfectious DiseasesSolubilityCOS CellsRecombinant DNAbiology.proteinViral loadCell DivisionPlasmidsJournal of Viral Hepatitis
researchProduct

Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins

1991

The envelope of hepatitis B virus contains three related proteins, one of which is myristylated. The nonmyristylated small and middle protein are assembled into empty envelope particles which are secreted from cells, whereas the myristylated large envelope protein is mainly found in complete virions and is not secreted in the absence of the nucleocapsid. The block to secretion can be partially overcome by mutation or deletion of the myristylation site. Creation of a myristyl attachment site in the small protein impairs the secretion of empty envelope particles but not their intracellular assembly. Myristylation may therefore play a crucial role in hepatitis B virus replication by channeling…

Hepatitis B virusvirusesDNA Mutational AnalysisImmunologyIn Vitro TechniquesBiologyVirus Replicationmedicine.disease_causeMyristic AcidMicrobiologyVirusStructure-Activity RelationshipCapsidViral Envelope ProteinsViral envelopeVirologymedicineHumansSecretionProtein PrecursorsHepatitis B virusMutationHepatitis B Surface Antigensbiology.organism_classificationVirologyCell CompartmentationMolecular WeightCapsidHepadnaviridaeViral replicationInsect ScienceMyristic AcidsProtein Processing Post-TranslationalResearch ArticleJournal of Virology
researchProduct

Different mechanisms of resistance to Bacillus thuringiensis toxins in the indianmeal moth.

2001

ABSTRACT Susceptibility to protoxin and toxin forms of Cry1Ab and the binding of 125 I-labeled Cry1Ab and Cry1Ac has been examined in three Plodia interpunctella colonies, one susceptible (688 s ) and two resistant (198 r and Dpl r ) to Bacillus thuringiensis . Toxicological studies showed that the 198 r colony was 11-fold more resistant to Cry1Ab protoxin than to Cry1Ab activated toxin, whereas the Dpl r colony was 4-fold more resistant to protoxin versus toxin. Binding results with 125 I-labeled toxins indicated the occurrence of two different binding sites for Cry1Ab in the susceptible insects, one of them shared with Cry1Ac. Cry1Ab binding was found to be altered in insects from both re…

InsecticidesBacterial ToxinsBacillus thuringiensisMothsmedicine.disease_causeApplied Microbiology and BiotechnologyBinding CompetitiveMicrobiologyToxicologyInsecticide ResistanceHemolysin ProteinsBacterial ProteinsBacillus thuringiensismedicineInvertebrate MicrobiologyAnimalsBinding siteProtein PrecursorsLarvaBacillaceaeEcologybiologyBacillus thuringiensis ToxinsMicrovilliToxinParasporal bodyfungibiology.organism_classificationBacillalesEndotoxinsCry1AcLarvaFood ScienceBiotechnologyApplied and environmental microbiology
researchProduct

Potassium-inhibited processing of IL-1 beta in human monocytes.

1995

Agents that deplete cells of K+ without grossly disrupting the plasma membrane were found to stimulate the cleavage of pro-interleukin (IL)-1 beta to mature IL-1 beta. Agents examined in this study included staphylococcal alpha-toxin and gramicidin, both of which selectively permeabilize plasma membranes for monovalent ions, the ionophores nigericin and valinomycin, and the Na+/K+ ATPase inhibitor ouabain. K+ depletion by brief hypotonic shock also triggered processing of pro-IL-1 beta. The central role of K+ depletion for inducing IL-1 beta maturation was demonstrated in cells permeabilized with alpha-toxin: processing of pro-IL-1 beta was totally blocked when cells were suspended in mediu…

LipopolysaccharidesCell Membrane PermeabilityNigericinATPaseEnzyme-Linked Immunosorbent AssayMonocytesGeneral Biochemistry Genetics and Molecular BiologyOuabainchemistry.chemical_compoundValinomycinAntibody SpecificityPotassium Channel BlockersExtracellularmedicineHumansChannel blockerProtein PrecursorsNa+/K+-ATPaseMolecular BiologyDose-Response Relationship DrugGeneral Immunology and MicrobiologybiologyGeneral NeurosciencechemistryBiochemistryType C PhospholipasesPotassiumBiophysicsbiology.proteinProtein Processing Post-TranslationalIntracellularResearch ArticleInterleukin-1medicine.drugThe EMBO Journal
researchProduct

Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19

2021

Abstract Objective The aim of the study was to assess the role of midregional proadrenomedullin (MR-proADM) in patients with COVID-19. Methods We included 110 patients hospitalized for COVID-19. Biochemical biomarkers, including MR-proADM, were measured at admission. The association of plasma MR-proADM levels with COVID-19 severity, defined as a requirement for mechanical ventilation or in-hospital mortality, was evaluated. Results Patients showed increased levels of MR-proADM. In addition, MR-proADM was higher in patients who died during hospitalization than in patients who survived (median, 2.59 nmol/L; interquartile range, 2.3–2.95 vs median, 0.82 nmol/L; interquartile range, 0.57–1.03; …

Lung DiseasesMalemedicine.medical_specialtySciencemedicine.medical_treatmentMR-proADMClinical BiochemistryComorbidityLabmed/1010Severity of Illness IndexGastroenterologyAdrenomedullinInterquartile rangeInternal medicineSeverity of illnessmedicineHumansAspartate AminotransferasesProtein PrecursorsSurvival analysisAgedRetrospective StudiesMechanical ventilationReceiver operating characteristicbiologyInterleukin-6SARS-CoV-2business.industryPatient SelectionBiochemistry (medical)C-reactive proteinCOVID-19Alanine TransaminaseRetrospective cohort studyMiddle AgedPrognosisSurvival Analysisrespiratory diseaseC-Reactive ProteininflammationHypertensionbiology.proteinbiomarkerBiomarker (medicine)FemaleTriagebusinessBiomarkersAcademicSubjects/MED00690Laboratory Medicine
researchProduct

Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population‐Based Gutenberg Health Study

2018

Background Preclinical data have indicated a link between use of vitamin K antagonists ( VKA ) and detrimental effects on vascular structure and function. The objective of the present study was to determine the relationship between VKA intake and different phenotypes of subclinical cardiovascular disease in the population. Methods and Results Clinical and laboratory data, as well as medical–technical examinations were assessed from 15 010 individuals aged 35 to 74 years during a highly standardized 5‐hour visit at the study center of the population‐based Gutenberg Health Study. In total, the study sample comprised 287 VKA users and 14 564 VKA nonusers. Multivariable analysis revealed an in…

Male0301 basic medicineEpidemiologyPROGRESSION030204 cardiovascular system & hematologyVitamin kCarotid Intima-Media ThicknessTHERAPYGastroenterologyAdrenomedullin0302 clinical medicineRisk Factorscardiovascular diseaseGermanyAtrial FibrillationNatriuretic Peptide BrainMatrix gla proteinOriginal ResearchVenous Thrombosisoral anticoagulationRISKbiologyMiddle AgedStrokevitamin K antagonistsC-Reactive ProteinCardiovascular DiseasesFemaleCardiology and Cardiovascular MedicineAtrial Natriuretic Factormedicine.drugAdultmedicine.medical_specialtyPopulation basedMATRIX GLA-PROTEINWARFARIN03 medical and health sciencesVascular StiffnessInternal medicineORAL ANTICOAGULANTmedicineHumansAnkle Brachial IndexVascular structureProtein PrecursorsAgedInflammationVascular diseasebusiness.industryWarfarinAnticoagulantsFibrinogenStroke Volumepharmacogenomic variantsARTERIALmedicine.diseasePreclinical dataPeptide FragmentsCALCIFICATION030104 developmental biologyAsymptomatic DiseasesPhenprocoumonbiology.proteinPulmonary EmbolismbusinessCalcificationJournal of the American Heart Association
researchProduct

Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.

2016

Natriuretic peptides are the standard biomarker for risk stratification in cardiovascular disease. Novel biomarkers of cardiovascular stress might allow refinement in risk stratification for patients with acute coronary syndrome (ACS). We tested the performance of these novel biomarkers for cardiovascular risk stratification in patients who presented with ACS.In the AtheroGene study, 873 patients presented with ACS in the emergency department. Biomarkers measured were: B-type natriuretic peptide (BNP), N-terminal pro BNP (NT-proBNP), midregional proatrial natriuretic peptide, midregional proadrenomedullin (MR-proADM), copeptin, and troponin I. The median follow-up time was 4 years and durin…

MaleAcute coronary syndromemedicine.medical_specialtyChest Painmedicine.drug_class030204 cardiovascular system & hematologyChest painCardiovascular SystemRisk Assessment03 medical and health sciencesAdrenomedullin0302 clinical medicineCopeptinStress PhysiologicalInternal medicineGermanyTroponin INatriuretic Peptide BrainmedicineNatriuretic peptideHumansAcute Coronary SyndromeProtein PrecursorsAgedProportional Hazards Modelsbiologybusiness.industryHazard ratioTroponin IGlycopeptidesReproducibility of Results030208 emergency & critical care medicineMiddle Agedmedicine.diseaseTroponinPeptide FragmentsCardiologybiology.proteinBiomarker (medicine)Femalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersThe Canadian journal of cardiology
researchProduct

Midregional Proadrenomedullin for Prediction of Cardiovascular Events in Coronary Artery Disease: Results from the AtheroGene Study

2011

Abstract BACKGROUND Midregional proadrenomedullin (MR-proADM) is a newly identified prognostic marker in heart failure. We evaluated the prognostic impact of MR-proADM in a cohort of patients with symptomatic coronary artery disease according to their clinical presentation. METHODS We measured baseline MR-proADM concentrations in 2240 individuals from the prospective AtheroGene study and evaluated the prognostic impact on future fatal and nonfatal cardiovascular events during a follow-up period of 3.6 (1.6) years. RESULTS The sample comprised 1355 individuals with stable angina pectoris (SAP) and 885 with acute coronary syndrome (ACS). A cardiovascular event occurred in 192 people. Individu…

MaleAcute coronary syndromemedicine.medical_specialtymedicine.drug_classClinical BiochemistryCoronary Artery DiseaseKaplan-Meier EstimateRisk AssessmentAngina PectorisCoronary artery diseaseAdrenomedullinPredictive Value of TestsInternal medicineDiabetes mellitusNatriuretic Peptide BrainmedicineNatriuretic peptideHumansProspective StudiesAcute Coronary SyndromeProtein PrecursorsAgedImmunoassayProportional hazards modelbusiness.industryBiochemistry (medical)Hazard ratioMiddle AgedPrognosismedicine.diseasePeptide FragmentsHeart failureLuminescent MeasurementsCohortCardiologyFemalebusinessBiomarkersClinical Chemistry
researchProduct